SCHEMBL8670718

SCHEMBL8670718

Cc1ccc(-c2ccnc(NC(=O)OC(C)(C)C)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.50
GSK3B P49841 1/20 0.48
DYRK1A Q13627 1/20 0.48
AAK1 Q2M2I8 8/20 0.47
TGFBR1 P36897 1/20 0.46
MAP4K4 O95819 1/20 0.46
PIK3C3 Q8NEB9 2/20 0.45
CYP17A1 P05093 3/20 0.45
IRAK4 Q9NWZ3 1/20 0.45
WNT3A P56704 1/20 0.44
NR3C2 P08235 1/20 0.44
CYP3A4 P08684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5251219 0.88 EGFR (0.57) FDPSGSK3BDYRK1AAAK1TGFBR1
SCHEMBL12127932 0.87 FDPS (0.54) FDPSGSK3BDYRK1AAAK1PIK3C3
SCHEMBL5544966 0.87 CYP17A1 (0.47) GSK3BDYRK1AAAK1TGFBR1MAP4K4
SCHEMBL5251601 0.86 GSK3B (0.46) GSK3BDYRK1AAAK1TGFBR1MAP4K4
SCHEMBL5548970 0.86 ATR (0.48) GSK3BDYRK1AAAK1MAP4K4PIK3C3
SCHEMBL9232528 0.85 CYP17A1 (0.50) GSK3BDYRK1AAAK1MAP4K4PIK3C3
SCHEMBL8675878 0.85 AAK1 (0.46) GSK3BDYRK1AAAK1MAP4K4PIK3C3
SCHEMBL828560 0.84 TP53 (0.51)
SCHEMBL29992322 0.84 AAK1 (0.48) GSK3BDYRK1AAAK1TGFBR1MAP4K4
SCHEMBL17643492 0.84 AAK1 (0.48) GSK3BDYRK1AAAK1TGFBR1MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5854245-A Fibrinogen receptor antagonists MERCK & CO., INC. (US) 1998-12-29 US disclosed
EP-0665223-A1 Antitumor agent, novel 3(2H)-pyridazinone derivatives and their preparation TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-08-02 EP disclosed